PLoS Biology (Mar 2021)

Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium.

  • Philip V'kovski,
  • Mitra Gultom,
  • Jenna N Kelly,
  • Silvio Steiner,
  • Julie Russeil,
  • Bastien Mangeat,
  • Elisa Cora,
  • Joern Pezoldt,
  • Melle Holwerda,
  • Annika Kratzel,
  • Laura Laloli,
  • Manon Wider,
  • Jasmine Portmann,
  • Thao Tran,
  • Nadine Ebert,
  • Hanspeter Stalder,
  • Rune Hartmann,
  • Vincent Gardeux,
  • Daniel Alpern,
  • Bart Deplancke,
  • Volker Thiel,
  • Ronald Dijkman

DOI
https://doi.org/10.1371/journal.pbio.3001158
Journal volume & issue
Vol. 19, no. 3
p. e3001158

Abstract

Read online

Since its emergence in December 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has spread globally and become a major public health burden. Despite its close phylogenetic relationship to SARS-CoV, SARS-CoV-2 exhibits increased human-to-human transmission dynamics, likely due to efficient early replication in the upper respiratory epithelium of infected individuals. Since different temperatures encountered in the human upper and lower respiratory tract (33°C and 37°C, respectively) have been shown to affect the replication kinetics of several respiratory viruses, as well as host innate immune response dynamics, we investigated the impact of temperature on SARS-CoV-2 and SARS-CoV infection using the primary human airway epithelial cell culture model. SARS-CoV-2, in contrast to SARS-CoV, replicated to higher titers when infections were performed at 33°C rather than 37°C. Although both viruses were highly sensitive to type I and type III interferon pretreatment, a detailed time-resolved transcriptome analysis revealed temperature-dependent interferon and pro-inflammatory responses induced by SARS-CoV-2 that were inversely proportional to its replication efficiency at 33°C or 37°C. These data provide crucial insight on pivotal virus-host interaction dynamics and are in line with characteristic clinical features of SARS-CoV-2 and SARS-CoV, as well as their respective transmission efficiencies.